Plot options



2. Select dataset:

Survival options

Survival INFO
Split patients by
Auto select best cutoff INFO
Trichotomization :  INFO

Restrict analysis to subtypes...

ER status: (n=1126)
PGR status: (n=946)
HER2 status: (n=704)

Stage: (n=923)
Grade: (n=160)
Lymph node status: (n=1153)

T: (n=984)
N: (n=859)
M: (n=757)

Restrict analysis to selected cohorts...

Race: (n=930)
Menopausal status: (n=125)

Radiation therapy: (n=122)
Hormone therapy: (n=1111)
Chemotherapy: (n=999)

Compare datasets

METABRIC: long follow-up (median: 94 months), average characteristics (78% ER positive, 12% HER2 positive), treatment data available for this dataset only!
TCGA: very short follow-up (median only 25 months), no grade.
GSE40267: almost exclusively ER negative patients (92%).
GSE19783: nodal status not available, 38% ER negative, high proportion of HER2 positive patients (18%).

By using the services, you agree to be bound by the Terms of Use.

Please note: the generated p value does not include correction for multiple hypothesis testing by default.

Please kindly cite our paper to support further development: Osz A, Lanczky A, Gyorffy B: Survival analysis in breast cancer using proteomic data from four independent datasets, Sci Rep 2021;11(1):16787. Copyright © 2009-2023 | Contact | Sitemap